ERTAPENEM QILU 1 g, powder for concentrate for infusion 10 bottles of 20 ml
Active ingredients: Ertapenem, Ertapenem sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for concentrate for infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERTAPENEM QILU 1 g, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacons en verre de 20 mL
- Marketing authorisation holder
- QILU PHARMA SPAIN (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60926401CIP73028992CIP133400930289921Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ERTAPÉNEMpoudre | 1,0 g · un flacon | FT |
| ERTAPÉNEM SODIQUEpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.